NCT00004235 - Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions

Esophageal CancerGastric Cancer

Interventions

DRUG

docetaxel

DRUG

irinotecan hydrochloride

Trial Locations (19)

48106

CCOP - Ann Arbor Regional, Ann Arbor

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

CentraCare Clinic, Saint Cloud

57709

Rapid City Regional Hospital, Rapid City

58122

CCOP - Merit Care Hospital, Fargo

58501

Medcenter One Health System, Bismarck

61602

CCOP - Illinois Oncology Research Association, Peoria

61801

CCOP - Carle Cancer Center, Urbana

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

70121

CCOP - Ochsner, New Orleans

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

17822-2001

CCOP - Geisinger Clinic and Medical Center, Danville

57105-1080

CCOP - Sioux Community Cancer Consortium, Sioux Falls

S4T 7T1

Allan Blair Cancer Centre, Regina

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER